The Zepbound LillyDirect offers comes in a single-dose vial rather than as an auto-injector pen, also called a Zepbound pen. The vial doses available are 2.5 mg and 5 mg, which is limited compared ...
A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
During his appearance on the " Armchair Expert " podcast on Monday, the "Frozen" actor opened up about taking weight loss ...
Novo Nordisk's CagriSema trial raised concerns as patients reported weight loss but significant side effects. Investors ...
The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go ...
An experimental drug called amycretin showed signs it could be more potent than Eli Lilly’s rival Zepbound, though analysts ...
“Each injection is painful.” In the recent study, researchers explored if the diabetes and obesity drug tirzepatide (the active ingredient in Zepbound and Mounjaro) could improve CGL, as it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback